SCHEDULE: Vanguard Reports Zero LeMaitre Vascular Stake After Realignment

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in LeMaitre Vascular Inc. following an internal corporate realignment.

Summary

• The Vanguard Group filed an Amendment No. 6 to Schedule 13G for LeMaitre Vascular Inc. common stock.
• The filing indicates that The Vanguard Group now beneficially owns 0.00 shares, representing 0% of the class of securities.
• This change is attributed to an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of Vanguard will report beneficial ownership separately (on a disaggregated basis) in reliance on SEC Release No. 34-39538 (January 12, 1998).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these disaggregated subsidiaries and/or business divisions.
• The subsidiaries and/or business divisions continue to pursue the same investment strategies as previously pursued by The Vanguard Group, Inc.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative development for LeMaitre Vascular Inc. due to the optics of a major institutional investor reporting zero beneficial ownership, despite the technical explanation of internal realignment. The market may react to the perceived reduction in institutional backing.

Negatives

• The Vanguard Group, a major institutional investor, now reports 0% beneficial ownership in LeMaitre Vascular Inc., which could be perceived negatively by some investors, despite the technical explanation.

Risks

• Potential negative market perception or investor sentiment due to a prominent institutional investor reporting zero beneficial ownership, even if it's a technical reporting change rather than a divestment.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding LeMaitre Vascular Inc.'s future performance or operations.

Management Comments

• The Vanguard Group, Inc. went through an internal realignment on January 12, 2026, leading to certain subsidiaries or business divisions reporting beneficial ownership separately.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

Industry Context

StockSavvy.ai notes that such disaggregated reporting by large asset managers like The Vanguard Group is a common practice for compliance and internal structuring, particularly for entities managing vast portfolios across various funds and investment vehicles. While the headline of 0% ownership might initially draw attention, it primarily reflects a change in reporting structure rather than a direct divestment decision by the broader Vanguard organization.

Comparison to Industry Standards

• StockSavvy.ai observes that large institutional investors frequently adjust their internal reporting structures and compliance methodologies, often leading to amended 13G filings. This is a standard compliance procedure for asset managers managing vast portfolios across various funds and entities, such as BlackRock or State Street, which also utilize similar disaggregated reporting for their diverse investment products.

Stakeholder Impact

• Shareholders of LeMaitre Vascular Inc. may react to the perceived reduction in institutional ownership by The Vanguard Group, potentially influencing trading activity and share price.

Key Dates

Recommendation

The filing primarily reflects an internal reporting change by The Vanguard Group, not a fundamental shift in LeMaitre Vascular Inc.'s business or prospects. While the optics of a major institutional investor reporting 0% beneficial ownership could cause short-term market jitters, it does not inherently signal a negative outlook on the issuer's performance. Investors should monitor subsequent filings from Vanguard's disaggregated entities to understand the true extent of their continued investment, maintaining a 'hold' position until further clarity emerges regarding actual investment levels.

Keywords

Vanguard Group, LeMaitre Vascular, Schedule 13G, Beneficial Ownership, Institutional Investor, SEC Filing, Corporate Realignment, Common Stock